InvestorsHub Logo
Followers 1
Posts 88
Boards Moderated 0
Alias Born 02/04/2006

Re: None

Thursday, 10/31/2013 8:10:57 AM

Thursday, October 31, 2013 8:10:57 AM

Post# of 426911
Thank you for all of you who have provided the share numbers. I will keep the tally and update every evening. I will expand this effort to the Yahoo board.

I also appreciate the kind comments and also empathize with the pain that everyone is going through. At this stage, I think we need to do all we can in a calm and effective manner and considering all options that we could impact. It appears clear to me that there are many talented and high level individuals that are invested in AMRN, number of owners are MDs, lawyers, and those with experience in finances and investment. I think it is imperative that we utilize everyone's expertise and consider all input to try to effect positive change.

I do think the chances for changing the FDA outcome is going to be very difficult and an uphill battle. On the other hand, we should do all we can to try to affect the outcome. IMV, completing the Reduce It is of paramount importance as positive outcome of that study is a complete gamechanger. The valuation after Reduce IT outcome will be in excess of $10 billion market cap. I do agree all options for funding Reduce It must be considered, including NIH funding, partnership with profit sharing, or buy out that has conditional link to Reduce It study.

I do thin we need to decide the combined strategy in a calculated manner but take action relatively soon. At this point zumandu has agreed to lead this effort and my understanding is that number of investors are in touch with zumantu. I also welcome anyone interested in contributing or having a leadership role in this effort.



By the way, I am an academic physician.

Speed
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News